This inventor holds 20 USPTO granted patents and 4 published patent applications and 5 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: University of Kansas, Amgen Inc., Southern Research Institute. Active years: 2009-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Simi Valley, CA (US) (2009 - 2012)
- Olathe, KS (US) (2011 - 2020)
- Madison, WI (US) (2022)
Company Filing History:
10 out of 573 
8 out of 2,077 
4 out of 205 
Years Active: 2009-2022
Areas of Expertise:
Title: Innovator Spotlight: Jennifer Elizabeth Golden
Introduction:
Jennifer Elizabeth Golden, a prolific inventor based in Olathe, Kansas, holds an impressive portfolio of 20 patents in the field of biomedical research and pharmaceuticals. Her groundbreaking work has significantly contributed towards the development of novel compounds and methods for treating various diseases associated with N-linked glycosylation and the Unfolded Protein Response.
Latest Patents:
1. "Inhibitors of-linked glycosylation and methods using same": Golden's innovative patent encompasses the development of novel compounds aimed at preventing or treating diseases linked to N-linked glycosylation. The methods involve administering these compounds to individuals in need, showcasing a promising approach towards disease management.
2. "Compounds and methods for activating the apoptotic arm of the unfolded protein response": Golden's patent introduces N-substituted sulfonylphenyl-5-nitrofuranyl-2-carboxamide derived compounds that selectively activate the apoptotic arm of the Unfolded Protein Response. This invention holds significant potential in treating diseases like diabetes, Alzheimer's, Parkinson's, hemophilia, lysosomal storage diseases, and cancer.
Career Highlights:
Jennifer Elizabeth Golden is a distinguished researcher affiliated with the University of Kansas. Her tenure at the prestigious institution has been marked by relentless dedication to innovation and a commitment to pushing the boundaries of biomedical science. Golden's contributions have not only enhanced the University's research reputation but have also paved the way for transformative advancements in healthcare.
Collaborations:
Throughout her career, Golden has collaborated closely with esteemed peers in the field of biomedical research. Notable colleagues include Jeffrey Aube and Roland W. Burli, whose combined expertise and synergistic efforts have led to the successful development and implementation of cutting-edge inventions in the medical domain.
Conclusion:
In conclusion, Jennifer Elizabeth Golden stands out as a visionary inventor whose pioneering work in biomedical research has left an indelible mark on the industry. Her remarkable patents, particularly in the realms of N-linked glycosylation and the Unfolded Protein Response, underscore her unwavering commitment to advancing healthcare solutions. With a strong foundation at the University of Kansas and supportive collaborations, Golden continues to drive innovation and shape the future of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile